Cost-effectiveness of MRI for breast cancer screening in BRCA1/2 mutation carriers

BACKGROUND: Women with mutations in BRCA1 or BRCA2 are at high risk of developing breast cancer and, in British Columbia, Canada, are offered screening with both magnetic resonance imaging (MRI) and mammography to facilitate early detection. MRI is more sensitive than mammography but is more costly...

Descripción completa

Detalles Bibliográficos
Autores principales: Pataky, Reka, Armstrong, Linlea, Chia, Stephen, Coldman, Andrew J, Kim-Sing, Charmaine, McGillivray, Barbara, Scott, Jenna, Wilson, Christine M, Peacock, Stuart
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3711845/
https://www.ncbi.nlm.nih.gov/pubmed/23837641
http://dx.doi.org/10.1186/1471-2407-13-339

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3711845/
https://www.ncbi.nlm.nih.gov/pubmed/23837641
http://dx.doi.org/10.1186/1471-2407-13-339

Ejemplares similares